Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus Pollinger

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Drug Targeting|May 8, 2015
Multivalent targeting of AT1 receptors with angiotensin II-functionalized nanoparticlesRobert Hennig, Klaus Pollinger, Joerg Tessmar, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 17, 2014
Nanoparticle multivalency counterbalances the ligand affinity loss upon PEGylationRobert Hennig, Klaus Pollinger, Anika Veser, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|May 8, 2008
Hyalocyte proliferation and ECM accumulation modulated by bFGF and TGF-beta1Florian Sommer, Klaus Pollinger, Ferdinand Brandl, et al.
Pharmaceutical Research|October 10, 2020
Fluorescent Nanoparticles Coated with a Somatostatin Analogue Target Blood Monocyte for Efficient Leukaemia TreatmentAhmed A H Abdellatif, Robert Hennig, Klaus Pollinger, et al.
Small (Weinheim an Der Bergstrasse, Germany)|August 14, 2012
Kidney podocytes as specific targets for cyclo(RGDfC)-modified nanoparticlesKlaus Pollinger, Robert Hennig, Miriam Breunig, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 24, 2015
Multivalent nanoparticles bind the retinal and choroidal vasculatureRobert Hennig, Andreas Ohlmann, Janina Staffel, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 27, 2013
Ligand-functionalized nanoparticles target endothelial cells in retinal capillaries after systemic applicationKlaus Pollinger, Robert Hennig, Andreas Ohlmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 26, 2010
G protein-coupled receptors function as logic gates for nanoparticle binding and cell uptakeWolfgang Hild, Klaus Pollinger, Andrea Caporale, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Drug Targeting|May 8, 2015
Multivalent targeting of AT1 receptors with angiotensin II-functionalized nanoparticlesRobert Hennig, Klaus Pollinger, Joerg Tessmar, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 17, 2014
Nanoparticle multivalency counterbalances the ligand affinity loss upon PEGylationRobert Hennig, Klaus Pollinger, Anika Veser, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|May 8, 2008
Hyalocyte proliferation and ECM accumulation modulated by bFGF and TGF-beta1Florian Sommer, Klaus Pollinger, Ferdinand Brandl, et al.
Pharmaceutical Research|October 10, 2020
Fluorescent Nanoparticles Coated with a Somatostatin Analogue Target Blood Monocyte for Efficient Leukaemia TreatmentAhmed A H Abdellatif, Robert Hennig, Klaus Pollinger, et al.
Small (Weinheim an Der Bergstrasse, Germany)|August 14, 2012
Kidney podocytes as specific targets for cyclo(RGDfC)-modified nanoparticlesKlaus Pollinger, Robert Hennig, Miriam Breunig, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 24, 2015
Multivalent nanoparticles bind the retinal and choroidal vasculatureRobert Hennig, Andreas Ohlmann, Janina Staffel, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 27, 2013
Ligand-functionalized nanoparticles target endothelial cells in retinal capillaries after systemic applicationKlaus Pollinger, Robert Hennig, Andreas Ohlmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 26, 2010
G protein-coupled receptors function as logic gates for nanoparticle binding and cell uptakeWolfgang Hild, Klaus Pollinger, Andrea Caporale, et al.
Pageof 1